With worldwide markets down substantially heading into the fourth quarter of 2015, Mackie Research Capital analyst Russell Stanley says he has identified a healthcare play that will buck the trend.
In a comprehensive report from Mackie Research Capital dedicated to their analyst’s top picks for Q4, Stanley says Nobilis Health Corp. (NHC-TSX) is his.
Nobilis, which owns and operates ambulatory surgical centers and surgical hospitals in parts of the United States, is a company with a track record of high organic growth, says Stanley. He also notes that Nobilis has a strong track record when it comes to M&A. He points to the company’s September 2014 acquisition of First Nobilis Hospital for $7.5 million in cash, as one example.
On September 23, Nobilis announced it had acquired a 60% stake and management control of the former Freedom Pain Hospital located in Scottsdale, Arizona for approximately $3.2-million.
The analyst says there are macro trends supporting the story as well.
“We view (Nobilis) as an undervalued play on increasing demand for surgical procedures flowing from an aging population and the prevalence of obesity,” says Stanley.
In the research update to clients this morning, Stanley reiterated his “Buy” rating and one year target price of $12.50 on Nobilis Health, implying a return of 72% at the time of publication.